CD8-depleted, non-engrafting, HLA-mismatched unrelated donor infusion
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD8-depleted, non-engrafting, HLA-mismatched unrelated donor infusion, covering 2025-10-22 to 2025-10-22. Get the full timeline:
Most recent: Clinical Trial Update: CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML [Phase 1, Phase 2]